159 related articles for article (PubMed ID: 12647219)
21. [Change of PML/PML-RARalpha protein during treatment with tetraarsenic tetrasulfide (As4S4) in patients with acute promyelocytic leukemia].
Wang JZ; Liu YR; Qin YZ; Jiang H; Wang FR; Bao L; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):464-8. PubMed ID: 14575537
[TBL] [Abstract][Full Text] [Related]
22. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
23. Retinoic acid attenuates promyelocytic leukemia protein-induced cell death in breast cancer cells by activation of the ubiquitin-proteasome pathway.
Son SH; Yu E; Ahn Y; Choi EK; Lee H; Choi J
Cancer Lett; 2007 Mar; 247(2):213-23. PubMed ID: 16740359
[TBL] [Abstract][Full Text] [Related]
24. [Effects of PML and PML-RAR alpha antisense oligonucleotides on promyelocytic leukemia cell line NB4].
Chen Y; Miao J; Fang Z
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):283-6. PubMed ID: 11778550
[TBL] [Abstract][Full Text] [Related]
25. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
26. Cell type- and differentiation stage-dependent expression of PML domains in rat, detected by monoclonal antibody HIS55.
Lam YW; Ammerlaan W; O WS; Kroese F; Opstelten D
Exp Cell Res; 1995 Dec; 221(2):344-56. PubMed ID: 7493633
[TBL] [Abstract][Full Text] [Related]
27. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
28. Effect of retinoic acid isomers on proliferation, differentiation and PML relocalization in the APL cell line NB4.
Zhu J; Shi XG; Chu HY; Tong JH; Wang ZY; Naoe T; Waxman S; Chen SJ; Chen Z
Leukemia; 1995 Feb; 9(2):302-9. PubMed ID: 7869768
[TBL] [Abstract][Full Text] [Related]
29. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
30. Promyelocytic leukaemia (PML) protein expression in human placenta and choriocarcinoma.
Kim CJ; Yoon BH; Jun JK; Park JO; Cho SY; Romero R; Kim YM; Yu ES
J Pathol; 2003 Sep; 201(1):83-9. PubMed ID: 12950020
[TBL] [Abstract][Full Text] [Related]
31. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
Yeager TR; Neumann AA; Englezou A; Huschtscha LI; Noble JR; Reddel RR
Cancer Res; 1999 Sep; 59(17):4175-9. PubMed ID: 10485449
[TBL] [Abstract][Full Text] [Related]
32. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Jansen J; Dejean A
Pathol Biol (Paris); 1995 Mar; 43(3):188-96. PubMed ID: 7675545
[TBL] [Abstract][Full Text] [Related]
33. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
[TBL] [Abstract][Full Text] [Related]
34. [Study of the effects of quercetin on PML gene and protein expression and localization in leukemia cells].
Zhong L; Chen F; Han J; Shao N; Ouyang R
Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):87-90. PubMed ID: 12015078
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the promyelocytic leukemia gene suppresses growth of human bladder cancer cells by inducing G1 cell cycle arrest and apoptosis.
He D; Nan X; Chang KS; Wang Y; Chung LW
Chin Med J (Engl); 2003 Sep; 116(9):1394-8. PubMed ID: 14527374
[TBL] [Abstract][Full Text] [Related]
36. Distinct nuclear body components, PML and SMRT, regulate the trans-acting function of HTLV-1 Tax oncoprotein.
Ariumi Y; Ego T; Kaida A; Matsumoto M; Pandolfi PP; Shimotohno K
Oncogene; 2003 Mar; 22(11):1611-9. PubMed ID: 12642864
[TBL] [Abstract][Full Text] [Related]
37. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
[TBL] [Abstract][Full Text] [Related]
38. Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells.
Ikeda T; Kimura F; Nakata Y; Sato K; Ogura K; Motoyoshi K; Sporn M; Kufe D
Cell Death Differ; 2005 May; 12(5):523-31. PubMed ID: 15746941
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
40. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein.
Vallian S; Gäken JA; Gingold EB; Kouzarides T; Chang KS; Farzaneh F
Oncogene; 1998 Jun; 16(22):2843-53. PubMed ID: 9671405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
